Recently there has also been a report on 64Cu-labeled bevacizumab for PET imaging of VEGF expression in colorectal cancer xenografts, which showed significant correlation of tumor accumulation of 64Cu-DOTA-bevacizumab with VEGF expression as measured by western blot analysis [101]. This evidence concerns the gene VEGFA and colorectal cancer.